期刊文献+

细胞色素P450 2C19遗传多态性的研究进展 被引量:4

Overview of the genetic polymorphism of cytochrome P450 2C19
下载PDF
导出
摘要 细胞色素P450 2C19是细胞色素P450酶家族中十分重要的一种,是在体内代谢的药物中,超过10%药物的主要代谢酶。CYP2C19具有高度的遗传多样性:不同的基因型,表型差异十分明显。CYP2C19基因多态性与多种药物的代谢以及疾病的易感性相关,本文就CYP2C19的多态性分布以及其与药物代谢和疾病易感性的研究进展加以阐述。 Cytochrome P450 2C19 is an important cytochrome P450 enzyme,and involved in more than 10%metabolism of the clinical drugs.It is a highly polymorphic gene,the expression of enzymatic activity is obvious among different genotype. CYP2C19 gene polymorphism related to the metabolism of multiple drug and susceptibility of disease.CYP2C19 polymorphism distribution was introduced in this review as well as its research progress in drug metabolism and disease susceptibility.
作者 兰冰 康龙丽
出处 《国外医学(医学地理分册)》 CAS 2015年第2期159-164,共6页 Foreign Medical Sciences:Section of Medgeography
基金 西藏自治区科技厅重点课题(2014) 西藏自治区重点学科 西藏高原相关疾病高校科研创新团队项目资助
关键词 细胞色素P450 2C19 基因多态性 药物代谢 疾病易感性 Cytochrome P450 2C19 genetic polymorphism drug metabolism disease susceptibility
  • 相关文献

参考文献52

  • 1Brown CM, Reisfeld B, Mayeno AN. Cytochromes P450:structure-based Summary of Biotransformations usingrepresentative substrates[J]. Drug Metab Rev,2008,40(1)-1-100.
  • 2Wilks A. Heme oxygenase ; evolution, structure, and mechanism[J]. Antioxid Redox Signal,2002,4(4) -603-614.
  • 3Lewis DF, Sheridan G. Cytochromes P450, oxygen, andevolution[J]. Scientific World J,2001,1 : 151-167.
  • 4Lewis DF. 57 varieties: the human cytochromes P450 [ J].Pharmacogenomics,2004,5(3) :305-318.
  • 5Wrighton SA, Stevens JC, Becker GW, et al. Isolation andcharacterization of human liver cytochrome P450 2C19 :correlation between 2C19 and S-mephenytoin 4/-hydroxylation[J]. Arch Biochem Biophys, 1993,306( 1) :240-245.
  • 6Desta Z,Zhao X,Shin JG, et al. Clinical significance of thecytochrome P450 2C19 genetic polymorphism [J]. ClinPharmacokinet,2002,41(12):913-958.
  • 7Payan M,Rouini MR, Tajik N, et al. Hydroxylation index ofomeprazole in relation to CYP2C19 polymorphism and sex in ahealthy Iranian population[J]. Daru,2014,22:81-82.
  • 8Sim SC’Risinger C,Dahl ML,et al. A common novel CYP2C19gene variant causes ultrarapid drug metabolism relevant for thedrug response to proton pump inhibitors and antidepressants[J]. Clin Pharmacol Ther,2006,79(1) :103-113.
  • 9Kimura M,Ieiri 1? Mamiya K, et al. Genetic polymorphism ofcytochrome P450s, CYP2C19, and CYP2C9 in a Japanesepopulation[J]? Ther Drug Monit,1998,20(3) :243-247.
  • 10Shin DJ,Kwon J,Park AR,et al. Association of CYP2C19 * 2and * 3 genetic variants with essential hypertension in koreans[J]. Yonsei Med J,2012,53(6) :1113-1119.

同被引文献73

  • 1陈騉,王睿.药物代谢酶细胞色素P4502C9研究进展[J].中国临床药理学与治疗学,2004,9(6):601-606. 被引量:15
  • 2陈坤,宋亮,金明娟,范春红,蒋沁婷,俞维萍.叶酸代谢酶基因多态与结直肠癌易感性的关系[J].中华肿瘤杂志,2006,28(6):429-432. 被引量:5
  • 3林莉,陈苏红,邹德勇,刘晓晴,王升启.实时荧光PCR法检测DPYD* 9等位基因的单核苷酸突变[J].军事医学科学院院刊,2006,30(3):233-235. 被引量:1
  • 4成碟,徐为人,刘昌孝.细胞色素P450(CYP450)遗传多态性研究进展[J].中国药理学通报,2006,22(12):1409-1414. 被引量:44
  • 5Tong WY, Dong X. Microbial biotransformation: recent developments on steroid drugs. Recent Pat Biotechnol, 2009, 3(2):141-153.
  • 6Donova MV, Egorova OV. Microbial steroid transformations: current state and prospects. Appl Microbiol Biotechnol, 2012, 94(6):1423- 1447.
  • 7Ortiz de Montellano PR. Cytochrome P450: structure, mechanism, and biochemistry. New York: Kluwer Academic/Plenum Publishers, 2005.
  • 8Urlacher VB, Girhard M. Cytochrome P450 monooxygenases: an update on perspectives for synthetic application. Trends Biotechnol, 2012, 30(1):26-36.
  • 9Torres Pazmifio DE, Winkler M, Glieder A, et al. Monooxygenases as biocatalysts: Classification, mechanistic aspects and biotechnological applications. J Biotechnol, 2010, 146(1-2):9-24.
  • 10van Beilen JB, Funhoff EG. Expanding the alkane oxygenase toolbox: new enzymes and applications. Curr Opin Biotechnol, 2005, 16(3): 308-314.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部